Oligonucleotide therapeutics infographic | Thermo Fisher Scientific

Oligonucleotide therapeutics have attracted much attention recently. They represent an up-and-coming class of therapeutic options that can lead to major advances in the treatment or cure of diseases, holding great potential for further development in human medicine.

Access the infographic to learn about:

Common types of oligonucleotide therapeutics
Milestones in oligonucleotide therapeutics
Main differences between ASOs and siRNAs
Oligonucleotide research areas for therapeutic development
Phosphoramidites in the development of oligonucleotide therapeutics
Future of oligonucleotide therapeutics

First name

Last name

Name of institution

Telephone

City

Postal code/Zip

What type of oligos are you working on for oligo therapeutics development? (check all that apply)*

Antisense oligos (ASOs)

Aptamers

Guide RNAs (gRNAs)

Small activating RNAs (saRNAs)

Small interfering RNAs (siRNAs)

Other

I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

Phone

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com
I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.